全文获取类型
收费全文 | 496篇 |
免费 | 26篇 |
国内免费 | 17篇 |
专业分类
耳鼻咽喉 | 3篇 |
儿科学 | 21篇 |
妇产科学 | 5篇 |
基础医学 | 48篇 |
口腔科学 | 44篇 |
临床医学 | 39篇 |
内科学 | 96篇 |
皮肤病学 | 16篇 |
神经病学 | 6篇 |
特种医学 | 94篇 |
外科学 | 53篇 |
综合类 | 27篇 |
预防医学 | 28篇 |
眼科学 | 7篇 |
药学 | 30篇 |
中国医学 | 1篇 |
肿瘤学 | 21篇 |
出版年
2023年 | 6篇 |
2022年 | 3篇 |
2020年 | 4篇 |
2018年 | 11篇 |
2017年 | 8篇 |
2016年 | 12篇 |
2015年 | 9篇 |
2014年 | 5篇 |
2013年 | 14篇 |
2012年 | 12篇 |
2011年 | 18篇 |
2010年 | 19篇 |
2009年 | 29篇 |
2008年 | 9篇 |
2007年 | 30篇 |
2006年 | 5篇 |
2005年 | 8篇 |
2004年 | 9篇 |
2003年 | 5篇 |
2002年 | 9篇 |
2001年 | 4篇 |
2000年 | 9篇 |
1999年 | 7篇 |
1998年 | 21篇 |
1997年 | 37篇 |
1996年 | 32篇 |
1995年 | 18篇 |
1994年 | 16篇 |
1993年 | 18篇 |
1992年 | 1篇 |
1991年 | 8篇 |
1990年 | 3篇 |
1989年 | 17篇 |
1988年 | 20篇 |
1987年 | 11篇 |
1986年 | 13篇 |
1985年 | 13篇 |
1984年 | 8篇 |
1983年 | 12篇 |
1982年 | 6篇 |
1981年 | 10篇 |
1980年 | 8篇 |
1979年 | 2篇 |
1978年 | 5篇 |
1977年 | 3篇 |
1976年 | 4篇 |
1975年 | 3篇 |
1970年 | 1篇 |
1969年 | 1篇 |
1885年 | 1篇 |
排序方式: 共有539条查询结果,搜索用时 15 毫秒
531.
Diurnal changes in colonic motor profile in conscious dogs 总被引:2,自引:0,他引:2
Continuous strain gauge recordings of ileal and proximal colonic motility were performed in 5 dogs fitted with a cannula in the ileum. The 22-hr records obtained with a normal ileocolonic transit were repeated during external deviation of digesta and after vagotomy. In the fasted state, the motility of the proximal colon was characterized by phases of contractions occurring at 25-min mean intervals modulated by the occurrence of migrating motor complexes on the ileum. Food intake induced three consecutive changes in colonic motility: a supplementary phase of activity immediately after the meal, an inhibition during the second postprandial hour, and a period of increased frequency of the phases of activity lasting 8-10 hr. The fasted motor profile of the proximal colon reappeared at the end of the postprandial disruption of the ileal cyclic activity. External deviation of ileal content abolished the late colonic response to the meal. Vagotomy did not modify any diurnal variation. 相似文献
532.
小梁切除术联合丝裂霉素C是治疗青少年型开角型青光眼(junior open-angle glaucoma,JOAG)较常用的术式,缺点是存在低眼压性黄斑病变、滤过泡渗漏等潜在并发症的可能.前房角切开术是治疗原发性婴幼儿型青光眼较常用的术式.作者报告了波士顿市马萨诸塞眼耳医院采用前房角切开这一轻度侵人性手术治疗青少年型开角型青光眼的结果. 相似文献
533.
Wei JW Fu SR Zhang J Gu DS Li XQ Chen XD Zhang ST He XF Yan JF Lu LG Tian J 《Hepatobiliary & pancreatic diseases international : HBPD INT》2022,21(4):325-333
BackgroundMacrovascular invasion (MaVI) occurs in nearly half of hepatocellular carcinoma (HCC) patients at diagnosis or during follow-up, which causes severe disease deterioration, and limits the possibility of surgical approaches. This study aimed to investigate whether computed tomography (CT)-based radiomics analysis could help predict development of MaVI in HCC.MethodsA cohort of 226 patients diagnosed with HCC was enrolled from 5 hospitals with complete MaVI and prognosis follow-ups. CT-based radiomics signature was built via multi-strategy machine learning methods. Afterwards, MaVI-related clinical factors and radiomics signature were integrated to construct the final prediction model (CRIM, clinical-radiomics integrated model) via random forest modeling. Cox-regression analysis was used to select independent risk factors to predict the time of MaVI development. Kaplan-Meier analysis was conducted to stratify patients according to the time of MaVI development, progression-free survival (PFS), and overall survival (OS) based on the selected risk factors.ResultsThe radiomics signature showed significant improvement for MaVI prediction compared with conventional clinical/radiological predictors (P < 0.001). CRIM could predict MaVI with satisfactory areas under the curve (AUC) of 0.986 and 0.979 in the training (n = 154) and external validation (n = 72) datasets, respectively. CRIM presented with excellent generalization with AUC of 0.956, 1.000, and 1.000 in each external cohort that accepted disparate CT scanning protocol/manufactory. Peel9_fos_InterquartileRange [hazard ratio (HR) = 1.98; P < 0.001] was selected as the independent risk factor. The cox-regression model successfully stratified patients into the high-risk and low-risk groups regarding the time of MaVI development (P < 0.001), PFS (P < 0.001) and OS (P = 0.002).ConclusionsThe CT-based quantitative radiomics analysis could enable high accuracy prediction of subsequent MaVI development in HCC with prognostic implications. 相似文献
534.
Joseph Sullivan Lieven Lagae J. Helen Cross Orrin Devinsky Renzo Guerrini Kelly G. Knupp Linda Laux Marina Nikanorova Tilman Polster Dinesh Talwar Berten Ceulemans Rima Nabbout Gail M. Farfel Bradley S. Galer Arnold R. Gammaitoni Michael Lock Anupam Agarwal Ingrid E. Scheffer the FAiRE DS Study Group 《Epilepsia》2023,64(10):2653-2666
Objective
This study was undertaken to assess the safety and efficacy of fenfluramine in the treatment of convulsive seizures in patients with Dravet syndrome.Methods
This multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase 3 clinical trial enrolled patients with Dravet syndrome, aged 2–18 years with poorly controlled convulsive seizures, provided they were not also receiving stiripentol. Eligible patients who had ≥6 convulsive seizures during the 6-week baseline period were randomized to placebo, fenfluramine .2 mg/kg/day, or fenfluramine .7 mg/kg/day (1:1:1 ratio) administered orally (maximum dose = 26 mg/day). Doses were titrated over 2 weeks and maintained for an additional 12 weeks. The primary endpoint was a comparison of the monthly convulsive seizure frequency (MCSF) during baseline and during the combined titration–maintenance period in patients given fenfluramine .7 mg/kg/day versus patients given placebo.Results
A total of 169 patients were screened, and 143 were randomized to treatment. Mean age was 9.3 ± 4.7 years (±SD), 51% were male, and median baseline MCSF in the three groups ranged 12.7–18.0 per 28 days. Patients treated with fenfluramine .7 mg/kg/day demonstrated a 64.8% (95% confidence interval = 51.8%–74.2%) greater reduction in MCSF compared with placebo (p < .0001). Following fenfluramine .7 mg/kg/day, 72.9% of patients had a ≥50% reduction in MCSF compared with 6.3% in the placebo group (p < .0001). The median longest seizure-free interval was 30 days in the fenfluramine .7 mg/kg/day group compared with 10 days in the placebo group (p < .0001). The most common adverse events (>15% in any group) were decreased appetite, somnolence, pyrexia, and decreased blood glucose. All occurred in higher frequency in fenfluramine groups than placebo. No evidence of valvular heart disease or pulmonary artery hypertension was detected.Significance
The results of this third phase 3 clinical trial provide further evidence of the magnitude and durability of the antiseizure response of fenfluramine in children with Dravet syndrome. 相似文献535.
536.
537.
Dong SC Bai DS Wang FA Jin SJ Zhang C Zhou BH Jiang GQ 《Hepatobiliary & pancreatic diseases international : HBPD INT》2023,22(6):605-614
Background: About 10%-20% of all individuals who develop hepatocellular carcinoma (HCC) do not have cirrhosis. Comparisons are rarely reported regarding the effectiveness of radiofrequency ablation (RFA) and liver resection (LR) in survival of HCC without cirrhosis and stratification by tumor size ≤ 5 cm.Methods: We used the Surveillance, Epidemiology, and End Results (SEER) database and identified 1505 patients with a solitary HCC tumor ≤ 5 cm who underwent RFA or LR during 2004-2015. Patients were classified into non-cirrhosis and cirrhosis groups and each group was categorized into three subgroups, according to tumor size ( ≤30 mm, 31-40 mm, 41-50 mm).Results: In patients without cirrhosis, LR showed better 5-year HCC cancer-specific survival than RFA in all tumor size subgroups ( ≤30 mm: 82.51% vs. 56.42%; 31-40 mm: 71.31% vs. 46.83%; 41-50 mm: 74.7% vs. 37.5%; all P < 0.05). Compared with RFA, LR was an independent protective factor for HCC cancer-specific survival in multivariate Cox analysis [ ≤30 mm: hazard ratio (HR) = 0.533, 95% confidence interval (CI): 0.313-0.908; 31-40 mm: HR = 0.439, 95% CI: 0.201-0.957; 41-50 mm: HR = 0.382; 95% CI: 0.159-0.916; all P < 0.05]. In patients with cirrhosis, for both tumor size ≤30 mm and 31-40 mm groups, there were no significant survival differences between RFA and LR in multivariate analysis (all P > 0.05). However, in those with tumor size 41-50 mm, LR showed significantly better 5-year HCC cancer-specific survival than RFA in both univariate (54.72% vs. 23.06%; P < 0.001) and multivariate analyses (HR = 0.297; 95% CI: 0.136-0.648; P = 0.002).Conclusions: RFA is an inferior treatment option to LR for patients without cirrhosis who have a solitary HCC tumor ≤5 cm. 相似文献
538.
H. Barry Waldman DDS MPH PhD Steven P. Perlman DDS MScD. DHL Allen Wong DS EdD 《Special care in dentistry》2017,37(4):159-163
A recent series of reports in Health Affairs reviewed the disparities in securing needed oral health services in the U.S. Despite an extensive oversight of the many issues involved, no direct mention is made of the particular conditions of the largest minority population in the U.S. unable to access dental care—the tens of millions of individuals with special health care needs. A review is provided of the particular barriers and conditions faced by this increasing population in its efforts to secure needed services. 相似文献
539.
Michael C. Stacey DS Steven A. Phillips MSc Forough Farrokhyar PhD Jillian M. Swaine BSc 《Wound repair and regeneration》2017,25(5):901-905
Area measurements of a chronic wound are the gold standard outcome measure to determine if a wound is on a healing or nonhealing trajectory. The use of digital planimetry can provide increased accuracy in measuring wound area however it is important to know the reliability and measurement error of these devices when used by multiple assessors. The aim of this study is to determine the within rater, between rater, and standard error of measurement of a digital planimetry device. Wound area in 42 patients was measured weekly for 12 weeks by two different raters, with each rater measuring the wound 10 times per visit. Intraclass correlation coefficients (ICC 1,k) and standard error of measurement were calculated for both within and between raters using 10 and the first three repeated measures to determine if using less measurements was as reliable. The true change in wound area was calculated by dividing stander error of measurements by mean wound areas. Within rater reliability for raters 1 and 2 were 0.995 and 0.992 for 10 measurements, and 0.996 and 0.992 for 3 measurements per time point. Between rater reliability was 0.979 for 10 measurements and 0.996 for 3 measurements per time point. The within rater standard error of measurement for raters 1 and 2 was 0.98 cm2 and 1.28 cm2 for 10 measurements and 0.895 cm2 and 1.29 cm2 for 3 measurements at each time point. The standard error of measurement for between raters was 2.07 cm2 for 10 measurements and 2.25 cm2 for 3 measurements per time point. The true change in wound size varied from 6.4% for within one rater to 15.7% for across different raters. This study found that both within and between rater reliability of the digital planimetry device was very high for three measurements per time point. 相似文献